GW869682

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2Obesity

Phase 1

Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs

CompletedNCT00494767

GlaxoSmithKlineDiabetes Mellitus, Type 2, Obesity

Start: 2006-09-29End: 2007-06-07Updated: 2017-08-07

Phase 2

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

CompletedNCT00297180

GlaxoSmithKlineObesity

Start: 2006-01-31End: 2006-09-30Updated: 2015-04-15